Redefining Adverse and Reverse Left Ventricular Remodeling by Cardiovascular Magnetic Resonance Following

Heerajnarain Bulluck1,2, Jaclyn Carberry3, David Carrick1,3

  • 1West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, Scotland (H.B., D.C., M.M., M.C.P., H.E., S.H., S.W., M.L., A.M., K.G.O., C.B.).

Insights

Adverse left ventricular remodeling after myocardial infarction, specifically a ≥12% increase in both LVESV and LVEDV, predicts worse long-term outcomes. This pattern of adverse remodeling is linked to significantly higher rates of death and heart failure hospitalization.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Clinical Research

Background:

  • Recent studies proposed cut-off values for changes in left ventricular end-diastolic volume (LVEDV) and LV end-systolic volume (LVESV) post-myocardial infarction.
  • Four distinct patterns of left ventricular (LV) remodeling were identified using cardiovascular magnetic resonance (CMR).

Purpose of the Study:

  • To evaluate the long-term prognostic significance of these identified patterns of LV remodeling.
  • To determine if specific LV remodeling patterns after ST-segment-elevation myocardial infarction (STEMI) correlate with clinical outcomes.

Main Methods:

  • A prospective cohort study included unselected STEMI patients.
  • Paired CMR scans were obtained at acute phase and 6 months post-STEMI.
  • The 5-year composite endpoint included all-cause death and heart failure hospitalization.

Main Results:

  • A total of 285 patients were followed for a median of 5.8 years.
  • Group 4 (adverse LV remodeling: ≥12% increase in both LVESV and LVEDV) showed significantly higher cumulative event rates (24.2%) compared to other groups.
  • Cox proportional hazard analysis revealed a significantly higher risk of adverse events in Group 4 (HR 3.0, P=0.015) compared to Group 1 (reverse remodeling).

Conclusions:

  • Adverse LV remodeling, defined as a ≥12% increase in both LVESV and LVEDV by CMR at 6 months, is associated with worse long-term clinical outcomes in STEMI patients.
  • The identified patterns of LV remodeling provide prognostic information for patients post-STEMI.
  • Reverse remodeling, no remodeling, and adverse remodeling with compensation showed similar long-term outcomes, distinct from severe adverse remodeling.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
323
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
249
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
558